Drug-Induced Thrombocytopenia Due to Nintedanib during Treatment of Idiopathic Pulmonary Fibrosis

Nintedanib is a tyrosine kinase inhibitor that was approved for the treatment of patients with idiopathic pulmonary fibrosis in 2014. The most common side effect of Nintedanib is diarrhea, and thrombocytopenia is a rare side effect of Nintedanib. The exact mechanism is unknown, and the literature la...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Igor Dumic, Antonios Charokopos, Angadabir Parmar, Christopher R. Grant, Ronin Joshua S. Cosiquien, Marilia Dagnon da Silva, Emilia Petcu
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	MDPI AG 2023-05-01
Sarja:	Medicina
Aiheet:	drug-induced thrombocytopenia idiopathic pulmonary fibrosis Nintedanib
Linkit:	https://www.mdpi.com/1648-9144/59/5/999
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!